hinotori与da Vinci机器人直肠手术短期结局比较
单中心回顾性研究纳入38例hinotori与96例da Vinci机器人直肠癌手术,倾向性评分匹配后各38例。hinotori组CD≥II级术后并发症发生率15.8%对18.4%,手术时间与操作台时间相当,出血量更少(9 vs 17.5 mL,p=0.025),两组均无中转,淋巴结清扫数与术后住院时间相似。结论支持hinotori用于直肠癌机器人手术的安全性不劣于da Vinci。
要点
- hinotori与da Vinci机器人直肠癌手术的CD≥II级并发症率相似(15.8% vs 18.4%)
- hinotori组出血量显著少于da Vinci组(9 vs 17.5 mL,p=0.025)
- 两组手术时间、操作台时间、淋巴结清扫数及术后住院时间相当
核心结论
- hinotori机器人系统用于直肠癌手术的安全性不劣于da Vinci系统。
研究设计与样本
- 采用倾向性评分匹配分析调整基线特征,匹配后两组各38例共76例。
主要发现
- 匹配后hinotori组与da Vinci组CD≥II级术后30天内并发症发生率分别为15.8%与18.4%。
- 手术时间280.5 vs 258 min,操作台时间166 vs 156 min,两组相当。
- hinotori组出血量少于da Vinci组(9 vs 17.5 mL,p=0.025)。
- 两组均无中转,淋巴结清扫数与术后住院时间相似。
临床怎么用
- hinotori可作为da Vinci之外直肠癌机器人手术的可行选择,短期安全结局相当。
局限性
- 单中心回顾性设计,样本量有限,仅报告短期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic surgery for rectal cancer has grown popular in recent years and has primarily used the da Vinci Surgical System (Intuitive Surgical, CA, USA; da Vinci). In 2020, Japan introduced the hinotori™ Surgical Robot System (Medicaroid, Kobe, Japan; hinotori). We report our initial surgical experiences with robotic surgery using hinotori for rectal cancer and its feasibility and safety comparing with da Vinci. METHODS: A single-institution retrospective study was conducted. Between November 2022 and November 2023, 38 and 96 patients with rectal cancer underwent robotic surgery using hinotori and da Vinci, respectively. The primary endpoint was the incidence of postoperative complications of the Clavien-Dindo classification (CD) grade ≥ II within postoperative 30 days. Secondary endpoints included surgical and console time, blood loss, conversion to other approaches, number of dissected lymph nodes, and postoperative hospital stay. A propensity score matching (PSM) analysis was used to adjust for imbalance in baseline characteristics. RESULTS: After PSM, a total of 76 patients (hinotori: 38, da Vinci: 38) were included. Compared to the da Vinci group, the hinotori group showed a similar postoperative complication rate of CD ≥ II (15.8% vs. 18.4%), comparable operative time (280.5 vs. 258 min), comparable console time (166 vs. 156 min), and less blood loss (9 vs. 17.5 mL, p = 0.025). There was no conversion in either group. The number of dissected nodes and postoperative stay were similar between the two groups. CONCLUSION: Our findings support that robotic surgery for rectal cancer using hinotori is as safe as surgery performed using the da Vinci system.
引用
- Tsujimura K, Nakauchi M, Hiro J, et al. Comparison of short-term outcomes for robotic rectal surgery between the hinotori™ surgical robot system and da Vinci surgical system: a single-center retrospective study using propensity score matching analysis. Surg Endosc. 2025. PMID: 40316750. doi:10.1007/s00464-025-11766-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。